 | Up a level |
2018
Cornely, Oliver A., Mullane, Kathleen M., Ostrosky-Zeichner, Luis, Maher, Rochelle M., Croos-Dabrera, Rodney, Lu, Qiaoyang, Lademacher, Christopher, Perfect, John R., Oren, Ilana, Schmitt-Hoffmann, Anne-Hortense, Giladi, Michael, Marty, Francisco M. 
ORCID: 0000-0002-3708-8734 and Rahav, Galia
(2018).
Isavuconazole for treatment of rare invasive fungal diseases.
Mycoses, 61 (8).
S. 518 - 534.
HOBOKEN:
WILEY.
ISSN 1439-0507
Marty, Francisco M. ORCID: 0000-0002-3708-8734, Cornely, Oliver A., Mullane, Kathleen M., Ostrosky-Zeichner, Luis, Maher, Rochelle M., Croos-Dabrera, Rodney, Lu, Qiaoyang, Lademacher, Christopher, Oren, Ilana, Schmitt-Hoffmann, Anne-Hortense, Giladi, Michael, Rahav, Galia and Perfect, John R.
(2018).
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
Mycoses, 61 (7).
S. 485 - 498.
HOBOKEN:
WILEY.
ISSN 1439-0507
2016
Cornely, Oliver A., Maher, Rochelle M., Marty, Francisco M. ORCID: 0000-0002-3708-8734, Lee, Misun, Vehreschild, J. Janne and Vehreschild, Maria J. G. T.
(2016).
The VITAL study: case control studies are hypothesis-generating Reply.
Lancet Infect. Dis., 16 (8).
S. 886 - 889.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1474-4457
Maertens, Johan A., Raad, Issam I., Marr, Kieren A., Patterson, Thomas F., Kontoyiannis, Dimitrios P., Cornely, Oliver A., Bow, Eric J., Rahav, Galia, Neofytos, Dionysios ORCID: 0000-0001-6970-2869, Aoun, Mickael, Baddley, John W., Giladi, Michael, Heinz, Werner J., Herbrecht, Raoul ORCID: 0000-0002-9381-4876, Hope, William ORCID: 0000-0001-6187-878X, Karthaus, Meinolf, Lee, Dong-Gun ORCID: 0000-0003-4655-0641, Lortholary, Olivier, Morrison, Vicki A., Oren, Ilana, Selleslag, Dominik, Shoham, Shmuel, Thompson, George R., III, Lee, Misun, Maher, Rochelle M., Schmitt-Hoffmann, Anne-Hortense, Zeiher, Bernhardt and Ullmann, Andrew J.
(2016).
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Lancet, 387 (10020).
S. 760 - 770.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X
Marty, Francisco M. ORCID: 0000-0002-3708-8734, Ostrosky-Zeichner, Luis, Cornely, Oliver A., Mullane, Kathleen M., Perfect, John R., Thompson, George R., III, Alangaden, George J., Brown, Janice M., Fredricks, David N., Heinz, Werner J., Herbrecht, Raoul ORCID: 0000-0002-9381-4876, Klimko, Nikolai, Klyasova, Galina, Maertens, Johan A., Melinkeri, Sameer R., Oren, Ilana, Pappas, Peter G., Racil, Zdenek, Rahav, Galia, Santos, Rodrigo, Schwartz, Stefan ORCID: 0000-0001-8833-5793, Vehreschild, J. Janne, Young, Jo-Anne H., Chetchotisakd, Ploenchan, Jaruratanasirikul, Sutep, Kanj, Souha S., Engelhardt, Marc, Kaufh, Achim, Ito, Masanori, Lee, Misun, Sasse, Carolyn, Maher, Rochelle M., Zeiher, Bernhardt and Vehreschild, Maria J. G. T.
(2016).
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
Lancet Infect. Dis., 16 (7).
S. 828 - 838.
OXFORD:
ELSEVIER SCI LTD.
ISSN 1474-4457